In recent years soluble bacterial antigens have been detected in serum and other body fluids from patients with various bacterial infections. Rytel et al (1974) have described two cases of fatal pneumococcal disease with disseminated intravascular coagulation (DIC) and circulating polysaccharide antigen. The serum levels of antigen were higher than in other cases of pneumococcal infections in which DIC did not develop, and the authors proposed that pneumococcal polysaccharides play a role in the pathogenesis of DIC. Similarly, Hoffman and Edwards (1972) Polysaccharides: Highly purified capsular polysaccharides from Neisseria meningitidis, groups A, B, and C, as well as from E. coli K 235 and E. coli Boston 12 were kindly provided by Dr E. Gotschlich, The Rockefeller University, New York (Gotschlich et al, 1969) . They were dissolved in water and thereafter stored in a frozen state.
Platelet-rich-plasma (PRP) was obtained by centrifuging anticoagulated blood for 20 minutes at 200 g. Platelet-poor-plasma (PPP) was obtained by centrifuging blood for 20 minutes at 18 000 g. The PRP was diluted with its own PPP to a final concentration of 200 000-250 000 platelets per ml.
Platelet aggregation was determined at 37°C by the photometric method described by Born (1962) and modified by O'Brien (1962) . The test substance, 0-1 ml, was added to 0 9 ml of PRP. Each substance was tested in heparinized as well as in citrated PRP from two humans and two dogs. The aggregation rate (decrease in optical density per minute) was calculated from the steepest slope of the initial aggregation curve (O'Brien et al, 1966 (Hjort and Rapaport, 1965; Levin, 1973) .
Thrombocytopenia and DIC may occur also in infections caused by Gram-positive bacteria, for instance pneumococci and streptococci, which do not elaborate endotoxin (Yoshikawa et al, 1971) . Recent investigations have shown an association between high serum levels of capsular polysaccharides and the presence of coagulation disorders in meningococcal and pneumococcal septicaemia, and it has been suggested that these substances are involved in the pathogenesis of DIC (Hoffman and Edwards, 1972; Rytel et al, 1974) .
This hypothesis was not supported by our results. We could not demonstrate any significant influence on human or dog platelet aggregation in vitro by polysaccharides derived from meningococci groups A, B, and C and two strains of E. coli. The absence of aggregation cannot be ascribed to suboptimal concentrations of divalent cations since the results were the same in heparinized and in citrated plasma. Salmonella typhi-murium endotoxin aggregated human platelets only slightly, while the effect on dog platelets was more pronounced. This is in agreement with the findings of others (Mustard and Packham, 1970; Ream et al, 1965; Nagayama et al, 1971) . The high concentrations of endotoxin, used to achieve only comparatively slight influence on platelet function in vitro, are discordant with the marked thrombocytopenia, which develops after injection of very small quantities of endotoxin into animals (Gilbert, 1960) . Endotoxin thus seems to exert its effect on platelets by some intermediary mechanism that is not functioning in vitro. It can not be excluded that capsular polysaccharides have a similar indirect effect on platelets, although it seems less likely in view of the general lack of toxicity of these substances. Thus meningococcal polysaccharides have been used for immunization against meningococcal disease with few side effects, and tests in mice and guinea pigs have not revealed any significant toxicity (Gotschlich et al, 1969) . 
